Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001123292-15-001273)

Filing Details

Accession Number:: 0001123292-15-001273
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-10-30 18:09:54
Reporting Period:: 2013-09-18

Filing Date:: 2015-10-30
Accepted Time:: 2015-10-30 18:09:54
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1175505	Five Prime Therapeutics Inc	FPRX	Pharmaceutical Preparations (2834)	260038620

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1578771	Julie Hambleton	C/O Five Prime Therapeutics, Inc. Two Corporate Drive South San Francisco CA 94080	Evp & Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-09-18	800	$14.75	800	No	4	P	Indirect	By husband's IRA
Common Stock	Acquisiton	2013-11-06	500	$10.10	1,300	No	4	P	Indirect	By husband's IRA
Common Stock	Acquisiton	2014-08-22	400	$10.75	1,700	No	4	P	Indirect	By husband's IRA
Common Stock	Acquisiton	2013-09-30	64	$13.70	64	No	4	P	Indirect	By son's custodial account

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By husband's IRA
No	4	P	Indirect	By husband's IRA
No	4	P	Indirect	By husband's IRA
No	4	P	Indirect	By son's custodial account

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	85,919	Direct

Footnotes

Includes 179 shares granted to the reporting person by the Issuer pursuant to a company match under the Issuer's 401(k) plan.